OCT-guided management of subclinical recurrent retinoblastoma

Ophthalmic Genet. 2018 Jun;39(3):338-343. doi: 10.1080/13816810.2018.1436183. Epub 2018 Feb 9.

Abstract

Purpose: Retinoblastoma (Rb) tumor recurrence in the papillary or macular region is a threat to life and visual prognosis respectively, making early detection indispensable. This study demonstrates the value of optical coherence tomography (OCT) in the early detection of subclinical tumor recurrence.

Methods: Since June 2012, hand-held SD-OCT (spectral domain Optical Coherence Tomography) of retro-equatorial foci, the optic head nerve and macula, is systematically performed under anesthesia in children treated and followed for Rb.

Results: Between June 2012 and January 2017, 16 subclinical recurrent tumors in 14 children were detected only by OCT in flat pigmented scars (n = 9), in type 2 regression (n = 3), on the optic nerve head (n = 3), and as secondary retinal seeding (n = 1).

Conclusion: OCT has become invaluable in the modern management of Rb. It allows not only early detection of a lesion before any tumor extension towards the macula or optic nerve head, but also the monitoring of the therapeutic response.

Keywords: Hand-held spectral-domain optical coherence tomography; intra-ocular tumor; retinoblastoma.

MeSH terms

  • Disease Management
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / surgery
  • Prognosis
  • Retinal Neoplasms / pathology*
  • Retinal Neoplasms / surgery
  • Retinoblastoma / pathology*
  • Retinoblastoma / surgery
  • Retrospective Studies
  • Tomography, Optical Coherence*